115 related articles for article (PubMed ID: 35810230)
1. 'At All Costs': Breast Cancer Patient Responses to Cost Transparency and Communication.
Gutnik LA; Fish LJ; Gallagher J; Greenup RA
Ann Surg Oncol; 2022 Nov; 29(12):7259-7260. PubMed ID: 35810230
[No Abstract] [Full Text] [Related]
2. Perspectives on the Costs of Cancer Care: A Survey of the American Society of Breast Surgeons.
Greenup RA; Rushing CN; Fish LJ; Lane WO; Peppercorn JM; Bellavance E; Tolnitch L; Hyslop T; Myers ER; Zafar SY; Hwang ES
Ann Surg Oncol; 2019 Oct; 26(10):3141-3151. PubMed ID: 31342390
[TBL] [Abstract][Full Text] [Related]
3. Discussing Health Care Expenses in the Oncology Clinic: Analysis of Cost Conversations in Outpatient Encounters.
Hunter WG; Zafar SY; Hesson A; Davis JK; Kirby C; Barnett JA; Ubel PA
J Oncol Pract; 2017 Nov; 13(11):e944-e956. PubMed ID: 28834684
[TBL] [Abstract][Full Text] [Related]
4. What does breast cancer treatment cost and what is it worth?
Hassett MJ; Elkin EB
Hematol Oncol Clin North Am; 2013 Aug; 27(4):829-41, ix. PubMed ID: 23915747
[TBL] [Abstract][Full Text] [Related]
5. Direct medical costs of breast cancer in Jordan: cost drivers and predictors.
Mousa R; Hammad E; Melhem J; Al-Jaghbir M
Expert Rev Pharmacoecon Outcomes Res; 2021 Aug; 21(4):647-654. PubMed ID: 33353434
[No Abstract] [Full Text] [Related]
6. The costs of treating breast cancer in Australia and the implications for breast cancer screening.
Butler JR; Furnival CM; Hart RF
Aust N Z J Surg; 1995 Jul; 65(7):485-91. PubMed ID: 7611968
[TBL] [Abstract][Full Text] [Related]
7. [Breast Cancer: Value-Based Healthcare, Costs and Financing].
Harfouche A; Silva S; Faria J; Araújo R; Gouveia A; Lacerda M; D'Orey L
Acta Med Port; 2017 Nov; 30(11):762-768. PubMed ID: 29279067
[TBL] [Abstract][Full Text] [Related]
8. [Cost of breast cancer treatment by clinical stage in the Basque Country, Spain].
Arrospide A; Soto-Gordoa M; Acaiturri T; López-Vivanco G; Abecia LC; Mar J
Rev Esp Salud Publica; 2015; 89(1):93-7. PubMed ID: 25946589
[TBL] [Abstract][Full Text] [Related]
9. Modelling the future costs of breast screening.
Johnston K
Eur J Cancer; 2001 Sep; 37(14):1752-8. PubMed ID: 11549428
[TBL] [Abstract][Full Text] [Related]
10. Variability in hospital treatment costs: a time-driven activity-based costing approach for early-stage invasive breast cancer patients.
Roman E; Cardoen B; Decloedt J; Roodhooft F
BMJ Open; 2020 Jul; 10(7):e035389. PubMed ID: 32641325
[TBL] [Abstract][Full Text] [Related]
11. The costs of treating breast cancer in the United Kingdom: implications for screening.
Wolstenholme JL; Smith SJ; Whynes DK
Int J Technol Assess Health Care; 1998; 14(2):277-89. PubMed ID: 9611903
[TBL] [Abstract][Full Text] [Related]
12. [The health care costs of breast cancer: the case of the Mexican Social Security Institute].
Knaul FM; Arreola-Ornelas H; Velázquez E; Dorantes J; Méndez O; Avila-Burgos L
Salud Publica Mex; 2009; 51 Suppl 2():s286-95. PubMed ID: 19967284
[TBL] [Abstract][Full Text] [Related]
13. The total hospital and community UK costs of managing patients with relapsed breast cancer.
Thomas RJ; Williams M; Marshall C; Glen J; Callam M
Br J Cancer; 2009 Feb; 100(4):598-600. PubMed ID: 19223909
[TBL] [Abstract][Full Text] [Related]
14. Breast cancer costs in New Zealand's public health system.
Lao C; Mondal M; Kuper-Hommel M; Campbell I; Cameron MP; Lawrenson R
N Z Med J; 2021 Nov; 134(1545):36-46. PubMed ID: 34788270
[TBL] [Abstract][Full Text] [Related]
15. Health system costs of metastatic breast cancer.
Wai ES; Trevisan CH; Taylor SCM ; Mates D; Jackson JS; Olivotto IA
Breast Cancer Res Treat; 2001 Feb; 65(3):233-40. PubMed ID: 11336245
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic and therapeutic approaches for nonmetastatic breast cancer in Canada, and their associated costs.
Will BP; Le Petit C; Berthelot JM; Tomiak EM; Verma S; Evans WK
Br J Cancer; 1999 Mar; 79(9-10):1428-36. PubMed ID: 10188886
[TBL] [Abstract][Full Text] [Related]
17. Estimating the costs of caring for the older breast cancer patient.
Hayman JA; Langa KM
Crit Rev Oncol Hematol; 2003 Jun; 46(3):255-60. PubMed ID: 12791425
[TBL] [Abstract][Full Text] [Related]
18. Economic analysis of psychosocial group therapy in women with metastatic breast cancer.
Lemieux J; Topp A; Chappell H; Ennis M; Goodwin PJ
Breast Cancer Res Treat; 2006 Nov; 100(2):183-90. PubMed ID: 16773438
[TBL] [Abstract][Full Text] [Related]
19. Use of data-mining to support real-world cost analyses: An example using HER2-positive breast cancer in Iran.
Ansaripour A; Zendehdel K; Tadayon N; Sadeghi F; Uyl-de Groot CA; Redekop WK
PLoS One; 2018; 13(10):e0205079. PubMed ID: 30273393
[TBL] [Abstract][Full Text] [Related]
20. Return on Investment Analysis of Breast Cancer Screening and Downstaging in Egypt: Implications for Developing Countries.
Skrundevskiy AN; Omar OS; Kim J; Soliman AS; Korolchuk TA; Wilson FA
Value Health Reg Issues; 2018 Sep; 16():22-27. PubMed ID: 29626738
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
